Error: Could not add to watchlist. X
+ Watchlist

Receptos Inc

RCPT:US
Acquired
RCPT:US was acquired by CELG:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.89
Market Cap (USD)
-
Shares Outstanding (m)
31.606
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Receptos, Inc. discovers and develops small molecule drug therapies. The Company specializes in the development of G protein-coupled receptors therapeutic candidates, as well as focuses on the discovery, development, and commercialization of various therapeutics for immune disorders.
Address
10835 Road to the Cure
Suite 205
San Diego, CA 92121
United States
Phone
1-858-652-5700